Medical alternatives to oocyte donation in women with premature ovarian failure: a systematic review - PubMed

Review

Medical alternatives to oocyte donation in women with premature ovarian failure: a systematic review

Ana Robles et al. Gynecol Endocrinol. 2013 Jul.

Free article

Abstract

Oocyte donation can satisfy the desire to have children in women with premature ovarian failure (POF) but little progress has been made to improve reproduction using the patients' own gametes. The aim of this study was to assess the effectiveness of alternative treatments to oocyte donation in patients with POF. A systematic search of MEDLINE, EMBASE and Cochrane databases from January 1988 to January 2012 using descriptors related to POF, ovulation induction, and pregnancy was made. Randomized clinical trials of women with POF undergoing various treatments to achieve ovulation induction, often compared with alternative treatment and placebo groups, were only selected. Outcomes of interest were those related to pregnancy (biochemical and live birth). Twelve trials were included and analysed for methodology, inclusion and exclusion criteria, number of patients included, characteristics and type of intervention, and results in terms of ovulation rate, pregnancy rate and ongoing pregnancy rate. The large methodological variability among studies prevented to combined data for a meta-analysis. None of the studies showed statistically significant differences between the study groups. The lack of case-control studies with a placebo group makes it impossible to establish differences between a treatment and no treatment.

Similar articles

• Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy.

  van Kasteren YM, Schoemaker J. van Kasteren YM, et al. Hum Reprod Update. 1999 Sep-Oct;5(5):483-92. doi: 10.1093/humupd/5.5.483. Hum Reprod Update. 1999. PMID: 10582785 Review.

• Reproductive outcomes of familial oocyte donation.

  Hasson J, Tulandi T, Son WY, Al Ma'mari N, Badeghiesh A, Tannus S, Takefman J, Shavit T. Hasson J, et al. Fertil Steril. 2016 Dec;106(7):1696-1702. doi: 10.1016/j.fertnstert.2016.08.042. Epub 2016 Sep 24. Fertil Steril. 2016. PMID: 27678040

• Pregnancy outcomes in women with primary ovarian insufficiency in assisted reproductive technology therapy: a retrospective study.

  Sun B, Li L, Zhang Y, Wang F, Sun Y. Sun B, et al. Front Endocrinol (Lausanne). 2024 Apr 29;15:1343803. doi: 10.3389/fendo.2024.1343803. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38745952 Free PMC article.

• Delaying the initiation of progesterone supplementation until the day of fertilization does not compromise cycle outcome in patients receiving donated oocytes: a randomized study.

  Escribá MJ, Bellver J, Bosch E, Sánchez M, Pellicer A, Remohí J. Escribá MJ, et al. Fertil Steril. 2006 Jul;86(1):92-7. doi: 10.1016/j.fertnstert.2005.12.048. Fertil Steril. 2006. PMID: 16818032 Clinical Trial.

• Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis.

  Bedaiwy MA, Abou-Setta AM, Desai N, Hurd W, Starks D, El-Nashar SA, Al-Inany HG, Falcone T. Bedaiwy MA, et al. Fertil Steril. 2011 Mar 1;95(3):906-14.e1-4. doi: 10.1016/j.fertnstert.2010.11.017. Epub 2010 Dec 10. Fertil Steril. 2011. PMID: 21145541 Review.

Cited by

• The Evaluation of Ovarian Function Recovery Following Treatment of Primary Ovarian Insufficiency: A Systematic Review.

  Kuang X, Tang Y, Xu H, Ji M, Lai D. Kuang X, et al. Front Endocrinol (Lausanne). 2022 Apr 28;13:855992. doi: 10.3389/fendo.2022.855992. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35573993 Free PMC article.

• Identification of transcriptome characteristics of granulosa cells and the possible role of UBE2C in the pathogenesis of premature ovarian insufficiency.

  Liu D, Guan X, Liu W, Jia Y, Zhou H, Xi C, Zhao M, Fang Y, Wu L, Li K. Liu D, et al. J Ovarian Res. 2023 Oct 17;16(1):203. doi: 10.1186/s13048-023-01266-3. J Ovarian Res. 2023. PMID: 37848988 Free PMC article.

• Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency.

  Craciunas L, Zdoukopoulos N, Vinayagam S, Mohiyiddeen L. Craciunas L, et al. Cochrane Database Syst Rev. 2022 Oct 6;10(10):CD008209. doi: 10.1002/14651858.CD008209.pub2. Cochrane Database Syst Rev. 2022. PMID: 36200708 Free PMC article. Review.

• Family size for women with primary ovarian insufficiency and their relatives.

  Verrilli LE, Allen-Brady K, Johnstone EB, Alvord MA, Welt CK. Verrilli LE, et al. Hum Reprod. 2023 Oct 3;38(10):1991-1997. doi: 10.1093/humrep/dead168. Hum Reprod. 2023. PMID: 37632248 Free PMC article.

• Effect of stem cell transplantation of premature ovarian failure in animal models and patients: A meta-analysis and case report.

  Chen L, Guo S, Wei C, Li H, Wang H, Xu Y. Chen L, et al. Exp Ther Med. 2018 May;15(5):4105-4118. doi: 10.3892/etm.2018.5970. Epub 2018 Mar 20. Exp Ther Med. 2018. PMID: 29755593 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Atypon

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Health Information